Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
Filana Therapeutics announced the publication in Epilepsia of preclinical data demonstrating that their drug candidate simufilam dose-dependently attenuates seizure progression in a mouse model of severe Tuberous Sclerosis Complex (TSC)-related epilepsy. The study supports continued clinical evaluation of simufilam for TSC-related epilepsy, a rare …